---
schema_version: "secwatch.filing_event.v1"
accession: "0000805928-22-000100"
form_type: "8-K"
ticker: "AXGN"
cik: "0000805928"
company_name: "Axogen, Inc."
filed_at: "2022-08-03T23:59:59+00:00"
generated_at: "2026-06-24T05:33:09.000741+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Axogen Q2 revenue $34.5M (+3% YoY); adjusted net loss narrows to $2.6M; reaffirms FY2022 guidance

## Summary
- Net revenue $34.5M, +3% YoY; ex-Avive (suspended June 2021) revenue grew 9%.
- Gross margin 81.8% vs 78.9% in Q2 2021 (included $1.4M Avive write-down).
- Adjusted net loss $2.6M ($0.06/share) vs loss $3.7M ($0.09/share) in Q2 2021.
- Cash+investments $64.3M, down from $73.7M at March 2022; $3.9M capex for Dayton facility.
- FY2022 revenue guidance reaffirmed at $135-142M; gross margin expected above 80%.

## SEC filing metadata
- accession: 0000805928-22-000100
- form_type: 8-K
- ticker: AXGN
- cik: 0000805928
- company_name: Axogen, Inc.
- filed_at: 2022-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/805928/000080592822000100/0000805928-22-000100-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/805928/000080592822000100/axgn-20220803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000805928-22-000100
- JSON: https://secwatch.observer/filing/0000805928-22-000100.json
- Plain text: https://secwatch.observer/filing/0000805928-22-000100.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.